Is Krsnaa Diagnostics Ltd debt-free?

Yes, Krsnaa Diagnostics Ltd is debt-free with a debt-to-equity ratio of 0.23.

Home

Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd Financials

Krsnaa Diagnostics Ltd Financial Statement

Krsnaa Diagnostics Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Mar 2025	Dec 2024	Sep 2024
Revenue	179.11	174.45	183.33
Operating Expense	121.35	117.26	126.24
Net Profit	21.07	21.60	21.97
Net Profit Margin	11.76	12.38	11.98
Earning Per Share	6.52	6.69	6.80
EBIDTA	58.50	54.25	55.66
Effective Tax Rate	15.37	6.70	8.93

Particulars	Mar 2025
Revenue	179.11
Operating Expense	121.35
Net Profit	21.07
Net Profit Margin	11.76
Earning Per Share	6.52
EBIDTA	58.50
Effective Tax Rate	15.37

Krsnaa Diagnostics Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	590.02	464.08	454.89
Operating Expenses Annual	443.86	339.84	320.34
Operating Profit Annual	162.96	143.66	149.48
Interest Annual	16.47	7.68	18.49
Depreciation	73.90	53.19	41.03
Net Profit Annual	58.56	63.51	70.70
Tax Annual	13.38	18.68	18.90

Particulars	Mar 2024
Total Revenue Annual	590.02
Operating Expenses Annual	443.86
Operating Profit Annual	162.96
Interest Annual	16.47
Depreciation	73.90
Net Profit Annual	58.56
Tax Annual	13.38

Krsnaa Diagnostics Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	22.13	88.32	24.68
Cash Flow from Operations	24.39	75.48	128.71
Cash Flow from Investing	-128.88	-108.54	-241.10
Cash Flow from Financing	84.21	-33.13	176.04
Cash Flow at the End	1.86	22.13	88.32

Particulars	Mar 2024
Cash Flow at the Beginning	22.13
Cash Flow from Operations	24.39
Cash Flow from Investing	-128.88
Cash Flow from Financing	84.21
Cash Flow at the End	1.86

Krsnaa Diagnostics Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	27.62	30.95	32.86
PBIT Margin (%)	14.98	19.37	23.76
PBT Margin (%)	14.07	16.85	22.47
Net PROFIT Margin (%)	9.93	13.69	15.54
Return On Networth / Equity (%)	7.52	8.89	19.71
Return On Networth /Employed (%)	9.79	11.47	16.99
Return On Assets (%)	6.45	8.07	11.50
Total Debt / Equity (X)	0.12	0.05	0.30
Asset Turnover Ratio (%)	0.65	0.59	0.74

Particulars	Mar 2024
PBDIT Margin (%)	27.62
PBIT Margin (%)	14.98
PBT Margin (%)	14.07
Net PROFIT Margin (%)	9.93
Return On Networth / Equity (%)	7.52
Return On Networth /Employed (%)	9.79
Return On Assets (%)	6.45
Total Debt / Equity (X)	0.12
Asset Turnover Ratio (%)	0.65

Krsnaa Diagnostics Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	647.16	470.68	385.69
Total Current Assets Annual	422.41	223.75	335.77
Non Current Assets Annual	749.16	685.64	541.29
Total Shareholders Funds Annual	815.24	742.50	686.75
Total Assets Annual	1,171.57	909.38	877.06

Particulars	Mar 2024
Fixed Assets Annual	647.16
Total Current Assets Annual	422.41
Non Current Assets Annual	749.16
Total Shareholders Funds Annual	815.24
Total Assets Annual	1,171.57

Krsnaa Diagnostics Ltd Earning Calls

EPS (INR)

Expected

6.40

Reported

6.40

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.00%

Dividend Pages

PE Ratio

FAQS on Krsnaa Diagnostics Ltd Financials

As of May 21, 2025, Krsnaa Diagnostics Ltd has a market capitalization of 2,536.04 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Krsnaa Diagnostics Ltd is with a debt-to-equity ratio of 0.23.

In FY 2024 , Krsnaa Diagnostics Ltd recorded a total revenue of approximately 681.70 Cr marking a significant milestone in the company's financial performance.

Krsnaa Diagnostics Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.2% annually, respectively..

Krsnaa Diagnostics Ltd's current PE ratio is 30.62.

Krsnaa Diagnostics Ltd's ROCE averaged 10.7% from the FY ending March 2023 to 2025, with a median of 11.1%. It peaked at 12.0% in March 2025, reflecting strong capital efficiency over the period..

Krsnaa Diagnostics Ltd's latest EBIT is Rs. 134.17 Cr, surpassing the average EBIT of Rs. 104.15 Cr over the 5 years..